Ingkil, Jerlyn B.

HRN: 26-35-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2025
CEFUROXIME 1.5GM (VIAL)
01/31/2025
02/01/2025
IV
1.5 Grams
Q8
OR Prophylaxis
Waiting Final Action 
01/31/2025
CEFUROXIME 1.5GM (VIAL)
01/31/2025
02/01/2025
IV
1.5gms
Q8hrs X 2 More Doses
S/P Primary LSTCS With IUD
Waiting Final Action 
01/31/2025
CEFUROXIME 500MG (TAB)
01/31/2025
02/06/2025
PO
500mg
BID X 7 Days
S/P Primary LSTCS With IUD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: